[1] GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020; 396, 1223−49. doi:  10.1016/S0140-6736(20)30752-2
[2] Rubio-Rivas M, Homs NA, Cuartero D, et al. The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: systematic review and meta-analysis. Autoimmun Rev, 2021; 20, 102713. doi:  10.1016/j.autrev.2020.102713
[3] Li CY, Zhang ZX, Luo XQ, et al. The triglyceride-glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning analysis. Cardiovasc Diabetol, 2025; 24, 47. doi:  10.1186/s12933-025-02591-1
[4] NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet, 2017; 389, 37−55. doi:  10.1016/S0140-6736(16)31919-5
[5] World Health Organization. More than 700 million people with untreated hypertension. https://www.who.int/news/item/25-08-2021-more-than-700-million-people-with-untreated-hypertension [Accessed 05 April 2024].
[6] Yaya S, El-Khatib Z, Ahinkorah BO, et al. Prevalence and socioeconomic factors of diabetes and high blood pressure among women in Kenya: a cross-sectional study. J Epidemiol Glob Health, 2021; 11, 397−404. doi:  10.1007/s44197-021-00004-6
[7] Alwadi Y, Al-Hemoud A, Khraishah H, et al. Impact of extreme heat on cardiovascular health in Kuwait: present and future projections. J Epidemiol Glob Health, 2024; 14, 1711−9. doi:  10.1007/s44197-024-00330-5
[8] Zhang XL, Huang D, Zhao JX, et al. Hypertension and burden of myocardial infarction in China: risk factors, gender differences and temporal trends from a National Chronic Disease Surveillance study (2021-2023). Blood Press, 2025; 34, 2487584. doi:  10.1080/08037051.2025.2487584
[9] National Bureau of Statistics. Wang Pingping: The total population has declined slightly, and the level of urbanization has continued to increase. https://www.stats.gov.cn/xxgk/jd/sjjd2020/202301/t20230118_1892285.html [Accessed 10 April 2024].
[10] Zhang M, Shi Y, Zhou B, et al. Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey. BMJ, 2023; 380, e071952.
[11] Shin J, Park JB, Kim KI, et al. 2013 Korean Society of Hypertension guidelines for the management of hypertension: part I–epidemiology and diagnosis of hypertension. Clin Hypertens, 2015; 21, 1. doi:  10.1186/s40885-014-0012-3
[12] Fan FF, Yuan ZW, Qin XH, et al. Optimal systolic blood pressure levels for primary prevention of stroke in general hypertensive adults: findings from the CSPPT (China Stroke Primary Prevention Trial). Hypertension, 2017; 69, 697−704. doi:  10.1161/HYPERTENSIONAHA.116.08499
[13] Liu XT, Mao ZX, Li YP, et al. Cohort Profile: The Henan Rural Cohort: a prospective study of chronic non-communicable diseases. Int J Epidemiol, 2019; 48, 1756−j. doi:  10.1093/ije/dyz039
[14] Wang Y, Li YQ, Liu XT, et al. The prevalence and related factors of familial hypercholesterolemia in rural population of China using Chinese modified Dutch Lipid Clinic Network definition. BMC Public Health, 2019; 19, 837. doi:  10.1186/s12889-019-7212-4
[15] World Health Organization. International guide for monitoring alcohol consumption and related harm. Geneva: World Health Organization, 2000.
[16] Wang SS, Lay S, Yu HN, et al. Dietary guidelines for Chinese residents (2016): comments and comparisons. J Zhejiang Univ Sci B, 2016; 17, 649−56. doi:  10.1631/jzus.B1600341
[17] Hallal PC, Andersen LB, Bull FC, et al. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet, 2012; 380, 247−57. doi:  10.1016/S0140-6736(12)60646-1
[18] Liu LS. 2010 Chinese guidelines for the management of hypertension. Chin J Cardiol, 2011; 39, 579−615. (In Chinese)
[19] Joint Committee for Guideline Revision. 2018 Chinese guidelines for prevention and treatment of hypertension-a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol, 2019; 16, 182−241.
[20] Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension, 2003; 42, 1206−52. doi:  10.1161/01.HYP.0000107251.49515.c2
[21] National Bureau of Statistics of the People’s Republic of China. China statistical yearbook 2010. China Statistics Press. 2010.
[22] Akimov AV, Gemueva KA, Semenova NK. The seventh population census in the PRC: results and prospects of the country's demographic development. Her Russ Acad Sci, 2021; 91, 724−35. doi:  10.1134/S1019331621060083
[23] Fryar, C. D. , Ostchega, Y. , Hales, C. M. , Zhang, G. , & Kruszon-Moran, D. (2017). Hypertension prevalence and control among adults: United States, 2015–2016. NCHS Data Brief, No. 289. National Center for Health Statistics. Available from: https://www.cdc.gov/nchs/data/databriefs/db289.htm[Accessed 24 April 2024].
[24] Lewington S, Lacey B, Clarke R, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med, 2016; 176, 524−32. doi:  10.1001/jamainternmed.2016.0190
[25] Wang YX, Peng XX, Nie XL, et al. Burden of hypertension in China over the past decades: systematic analysis of prevalence, treatment and control of hypertension. Eur J Prev Cardiol, 2016; 23, 792−800. doi:  10.1177/2047487315617105
[26] Liu XT, Li YQ, Guo Y, et al. The burden, management rates and influencing factors of high blood pressure in a Chinese rural population: the Rural Diabetes, Obesity and Lifestyle (RuralDiab) study. J Hum Hypertens, 2018; 32, 236−46. doi:  10.1038/s41371-018-0039-0
[27] Ihm SH, Bakris G, Sakuma I, et al. Controversies in the 2017 ACC/AHA hypertension guidelines: who can be eligible for treatments under the new guidelines?―An Asian perspective. Circ J, 2019; 83, 504−10. doi:  10.1253/circj.CJ-18-1293
[28] Evbayekha EO, Okobi OE, Okobi T, et al. The evolution of hypertension guidelines over the last 20+ years: a comprehensive review. Cureus, 2022; 14, e31437.
[29] Wang JG. Chinese hypertension guidelines. Pulse, 2015; 3, 14−20. doi:  10.1159/000382025
[30] Li LM, Rao KQ, Kong LZ, et al. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol, 2005; 26, 478−84. (In Chinese)
[31] Fan GH, Wang ZW, Zhang LF, et al. Prevalence, awareness, treatment and control of hypertension in rural areas in North China in 2013. Nat Med J China, 2015; 95, 616−20. (In Chinese)
[32] Yang L, Yan J, Tang XH, et al. Prevalence, awareness, treatment, control and risk factors associated with hypertension among adults in Southern China, 2013. PLoS One, 2016; 11, e0146181. doi:  10.1371/journal.pone.0146181
[33] Huang MX, Bliwise DL, Hall MH, et al. Association of depressive symptoms with sleep disturbance: a co-twin control study. Ann Behav Med, 2022; 56, 245−56. doi:  10.1093/abm/kaab040
[34] Agresti A. Categorical data analysis. 3rd ed. John Wiley & Sons. 2012.
[35] Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. 2nd ed. John Wiley & Sons. 2011.
[36] Wang H, Zhang XW, Zhang J, et al. Factors associated with prevalence, awareness, treatment and control of hypertension among adults in Southern China: a community-based, cross-sectional survey. PLoS One, 2013; 8, e62469. doi:  10.1371/journal.pone.0062469
[37] Sun HL, Zhao T, Zhang DD, et al. Interactions of vitamin D receptor polymorphisms with hypertriglyceridemia and obesity in Chinese individuals susceptible to hypertension and diabetes comorbidity. Biomed Environ Sci, 2023; 36, 196−200.
[38] Lei Z, Jia YN, Liu QSJ, et al. Association between mitochondrial DNA methylation and hypertension risk: a cross-sectional study in Chinese Northern population. Biomed Environ Sci, 2023; 36, 972−8.
[39] Wu RY, Kang N, Zhang CY, et al. Long-term exposure to PM2.5 and its components is associated with elevated blood pressure and hypertension prevalence: evidence from rural adults. J Adv Res, 2024; 60, 173−81. doi:  10.1016/j.jare.2023.07.012